PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1185 (107th)

Global Access to HIV/AIDS Medicines Act of 2001

referredUnited States· United States Congress· EN

Introduced

22 March 2001

Last action

22 March 2001 · Introduced

Status

Referred to the House Committee on International Relations.

Sponsors

Barbara Lee, Rep. Schakowsky, Janice D. [D-IL-9], Sen. Sanders, Bernard [I-VT], Del. Christensen, Donna M. [D-VI-At Large], Rep. Davis, Danny K. [D-IL-7], Rep. Millender-McDonald, Juanita [D-CA-37], Sheila Jackson Lee, Rep. Jones, Stephanie Tubbs [D-OH-11], Rep. Kilpatrick, Carolyn C. [D-MI-13], Maxine Waters, Rep. Wynn, Albert Russell [D-MD-4], James Clyburn, JOHN CONYERS, Sen. Baldwin, Tammy [D-WI], Rep. Carson, Julia [D-IN-7], Rep. Owens, Major R. [D-NY-12], ELIJAH CUMMINGS, Del. Norton, Eleanor Holmes [D-DC-At Large]

Subjects

Transport

Source updated

19 August 2025

Transport

Summary

Global Access to HIV/AIDS Medicines Act of 2001 - Prohibits funds appropriated to U.S. Federal agencies from being expended to seek, through negotiation or otherwise, the revocation or revision of intellectual property law or policy of a developing country that regulates HIV/AIDS pharmaceuticals or medical technologies, if such law or policy: (1) promotes access to HIV/AIDS pharmaceuticals or medical technologies to the country's population; and (2) provides adequate and effective intellectual property protection consistent with the Agreement on Trade-Related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act. Includes among such developing countries any sub-Saharan African country five percent or more of whose population is infected with HIV, or whose government has declared a national emergency with respect to HIV/AIDS. Encourages such developing countries to implement policies designed to address the underlying causes of the HIV/AIDS crisis by making efforts to encourage practices that will prevent further transmission and infection and to stimulate development of the infrastructure necessary to deliver adequate health services, including policies that provide an incentive for public and private research on, and development of, vaccines and other medical innovations that will combat the HIV/AIDS epidemic, particularly in Africa.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 March 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 22 March 2001

    Introduced

    Referred to the House Committee on International Relations.

    Source: IntroReferral

  3. 22 March 2001

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.